Skip to main content

Highlights

  1. 1
    Journal of neuroinflammation · 2020
    PMID: 32552741PMCID: PMC7298825DOISenior author109 citations
  2. 2
    ACS chemical neuroscience · 2020
    PMID: 32786303PMCID: PMC8325170DOIFirst author13 citations
  3. 3
    Molecular neurodegeneration · 2025
    PMID: 41331787PMCID: PMC12673724DOISenior author5 citations

Publications

60 publications

Active

6 grants
  • MPI
    CH25H mediates microglial neuroinflammation and tau toxicities in AD
    National Institute on Aging · 2025–2030
    R01AG096902-02
  • Co-I
    Discovery of first-in-class small molecule TREM2 ligands as therapeutics for Alzheimer's disease
    National Institute on Aging · 2024–2029
    R01AG083512-01A1
  • Co-I
    Validating STING as a therapeutic target for Parkinson disease using human iPSC models (MJFF-028881) to 2026 RFA: T2T Neuroinflammation Target Validation
    Michael J. Fox Foundation for Parkinson's Research · 2026–2028
    MJFF-028881
  • Co-I
    Systematic Identification of Biomarkers to Distinguish FTD-Tau from TDP-43
    Rainwater Charitable Foundation · 2026–2027
    RCF 261005-01
  • KP
    Modeling pathological Tau propagation in human brain cells in vivo
    BrightFocus Foundation · 2024–2026
    A2024003F
  • Co-I
    Elucidating the Cell-Type Specific Neuroprotective Mechanisms in the APOE3 Christchurch Mutation in Alzheimer's Disease
    National Institute on Aging · 2023–2026Fellowship
    F32AG085960-01
Completed grants (9)
  • PI
    Essential roles of DAP12 in tau metabolism and inflammation in Alzheimer's disease
    National Institute on Aging · 2020–2025
    R01AG064239-05
  • Co-I
    Linking tau proteostasis with neuronal activity in FTD
    National Institute of Neurological Disorders and Stroke · 2018–2023
    U54NS100717-03
  • Co-I
    The functions of the endolysosomal system in the interaction between amyloid plaques and microglia
    Cornell University - Ithaca · 2018–2020
    CU 190470-01
  • Co-I
    Molecular mechanisms in progranulin deficient frontotemporal dementia
    National Institute on Aging · 2019–2020
    R01AG051390-05
  • PI
    Retromer Chaperone R33 Selectively Promotes Aß Degradation by Microglia
    BrightFocus Foundation · 2016–2019
    BFF 170911-03
  • PI
    Investigating the Role of Microglia in Tau Clearance in Alzheimers Disease
    Coins for Alzheimer's Research Trust · 2015–2018
    CART 180604-02EWOF
  • KP
    Effect of APOE on CNS neurons: Role of LRP
    National Institute of Neurological Disorders and Stroke · 2014–2017 · via Washington University, The
    R01NS090934-20
  • PI
    The role of Hsp 90 in Alzheimer's Disease
    NIA · 2010–2016 · via NIH RePORTER
    K01AG032364-05
  • PI
    Roles of PEN-2 and APH-1 in PS1 complex formation
    NIA · 2003–2006 · via NIH RePORTER
    F32AG023432-03

News mentions

External relationships

Ownership

Aeton Therapeutics Inc.

Other

Aeton Therapeutics Inc.